ANI Pharmaceuticals
ANIP
ANIP
207 hedge funds and large institutions have $1.14B invested in ANI Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 87 increasing their positions, 43 reducing their positions, and 31 closing their positions.
Holders
207
Holders Change
+6
Holders Change %
+2.99%
% of All Funds
2.99%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
38
Increased
87
Reduced
43
Closed
31
Calls
$721K
Puts
$793K
Net Calls
-$72K
Net Calls Change
-$2.67M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$42.7M |
2 |
2
Pacer Advisors
Malvern,
Pennsylvania
|
$33.9M |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$33.1M |
4 |
4
Millennium Management
New York
|
$31.6M |
5 |
SCM
5
Soleus Capital Management
Greenwich,
Connecticut
|
$16M |